The multifaceted biology of plasmacytoid dendritic cells

Nature Reviews Immunology

Volumn 15, Issue 8, 2015, Pages 471-485

  Swiecki, Melissa ^a,b   Colonna, Marco ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Spring House   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; MICRORNA; TOLL LIKE RECEPTOR 12; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; CYTOKINE;

ANTIGEN PRESENTING CELL; ANTIVIRAL ACTIVITY; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CELL DIFFERENTIATION; CELL MIGRATION; CELL SURFACE; HUMAN; IMMUNE RESPONSE; INNATE IMMUNITY; MACROPHAGE; MUCOSAL IMMUNITY; NONHUMAN; PHENOTYPE; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; VIRUS INFECTION; ADAPTIVE IMMUNITY; ANIMAL; ANTIGEN PRESENTATION; DENDRITIC CELL; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; MOUSE; PATHOLOGY; SIGNAL TRANSDUCTION; VIROLOGY;

ADAPTIVE IMMUNITY; ANIMALS; ANTIGEN PRESENTATION; AUTOIMMUNE DISEASES; AUTOIMMUNITY; CYTOKINES; DENDRITIC CELLS; GENE EXPRESSION REGULATION; HUMANS; IMMUNITY, INNATE; INTERFERON TYPE I; MICE; SIGNAL TRANSDUCTION; VIRUS DISEASES;

EID: 84937967684     PISSN: 14741733     EISSN: 14741741     Source Type: Journal    
DOI: 10.1038/nri3865     Document Type: Review

References (252)

1. Lennert, K. & Remmele, W. Karyometric research on lymph node cells in man. I. Germinoblasts, lymphoblasts and lymphocytes. Acta Haematol. 19, 99-113 (in German) (1958).
2. Siegal, F. P. et al. The nature of the principal type 1 interferon-producing cells in human blood. Science 284, 1835-1837 (1999).
3. Cella, M. et al. Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat. Med. 5, 919-923 (1999).
4. Howell, D. M., Feldman, M., Siegal, F. P., Pettera, L. & Fitzgerald-Bocarsly, P. Peripheral blood of AIDS patients contains cells capable of providing accessory function for the natural killer cell-mediated, lysis of herpes simplex virus-infected targets despite low interferon-- production. J. Acquir. Immune Def. Syndr. 6, 15-23 (1993).
5. Perussia, B., Fanning, V. & Trinchieri, G. A leukocyte subset bearing HLA-DR antigens is responsible for in vitro - interferon production in response to viruses. Nat. Immun. Cell Growth Regul. 4, 120-137 (1985).
6. Gilliet, M., Cao, W. & Liu, Y. J. Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases. Nat. Rev. Immunol. 8, 594-606 (2008).
7. Blasius, A. L. & Beutler, B. Intracellular toll-like receptors. Immunity 32, 305-315 (2010).
8. Kawai, T. & Akira, S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 34, 637-650 (2011).
9. Asselin-Paturel, C. et al. Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology. Nat. Immunol. 2, 1144-1150 (2001).
10. Bjorck, P. Isolation and characterization of plasmacytoid dendritic cells from Flt3 ligand and granulocyte-macrophage colony-stimulating factor-treated mice. Blood 98, 3520-3526 (2001).
11. Nakano, H., Yanagita, M. & Gunn, M. D. CD11c+B220+Gr-1+ cells in mouse lymph nodes and spleen display characteristics of plasmacytoid dendritic cells. J. Exp. Med. 194, 1171-1178 (2001).
12. Facchetti, F., Vermi, W., Mason, D. & Colonna, M. The plasmacytoid monocyte/interferon producing cells. Virchows Arch. 443, 703-717 (2003).
13. Matsui, T. et al. CD2 distinguishes two subsets of human plasmacytoid dendritic cells with distinct phenotype and functions. J. Immunol. 182, 6815-6823 (2009).
14. Neil, S. J., Zang, T. & Bieniasz, P. D. Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 451, 425-430 (2008).
15. Blasius, A. L. et al. Bone marrow stromal cell antigen 2 is a specific marker of type I IFN-producing cells in the naive mouse, but a promiscuous cell surface antigen following IFN stimulation. J. Immunol. 177, 3260-3265 (2006).
16. Blasius, A. L., Cella, M., Maldonado, J., Takai, T. & Colonna, M. Siglec-H is an IPC-specific receptor that modulates type I IFN secretion through DAP12. Blood 107, 2474-2476 (2006).
17. Zhang, J. et al. Characterization of Siglec-H as a novel endocytic receptor expressed on murine plasmacytoid dendritic cell precursors. Blood 107, 3600-3608 (2006).
18. Puttur, F. et al. Absence of Siglec-H in MCMV infection elevates interferon - production but does not enhance viral clearance. PLoS Pathog. 9, e1003648 (2013).
19. Kopatz, J. et al. Siglec-H on activated microglia for recognition and engulfment of glioma cells. Glia 61, 1122-1133 (2013).
20. Satpathy, A. T. et al. Zbtb46 expression distinguishes classical dendritic cells and their committed progenitors from other immune lineages. J. Exp. Med. 209, 1135-1152 (2012).
21. Swiecki, M. et al. Cell depletion in mice that express diphtheria toxin receptor under the control of SiglecH encompasses more than plasmacytoid dendritic cells. J. Immunol. 192, 4409-4416 (2014).
22. Naik, S. H. et al. Development of plasmacytoid and conventional dendritic cell subtypes from single precursor cells derived in vitro and in vivo. Nat. Immunol. 8, 1217-1226 (2007).
23. Onai, N. et al. Identification of clonogenic common Flt3+M-CSFR+ plasmacytoid and conventional dendritic cell progenitors in mouse bone marrow. Nat. Immunol. 8, 1207-1216 (2007).
24. Reizis, B. Regulation of plasmacytoid dendritic cell development. Curr. Opin. Immunol. 22, 206-211 (2010).
25. Satpathy, A. T., Wu, X., Albring, J. C. & Murphy, K. M. Re(de)fining the dendritic cell lineage. Nat. Immunol. 13, 1145-1154 (2012).
26. Belz, G. T. & Nutt, S. L. Transcriptional programming of the dendritic cell network. Nat. Rev. Immunol. 12, 101-113 (2012).
27. Onai, N. et al. A clonogenic progenitor with prominent plasmacytoid dendritic cell developmental potential. Immunity 38, 943-957 (2013).
28. Cisse, B. et al. Transcription factor E2-2 is an essential and specific regulator of plasmacytoid dendritic cell development. Cell 135, 37-48 (2008).
29. Schlitzer, A. et al. Identification of CCR9-murine plasmacytoid DC precursors with plasticity to differentiate into conventional DCs. Blood 117, 6562-6570 (2011).
30. Schlitzer, A. et al. Tissue-specific differentiation of a circulating CCR9-pDC-like common dendritic cell precursor. Blood 119, 6063-6071 (2012).
31. Shigematsu, H. et al. Plasmacytoid dendritic cells activate lymphoid-specific genetic programs irrespective of their cellular origin. Immunity 21, 43-53 (2004).
32. Res, P. C., Couwenberg, F., Vyth-Dreese, F. A. & Spits, H. Expression of pT- mRNA in a committed dendritic cell precursor in the human thymus. Blood 94, 2647-2657 (1999).
33. Bendriss-Vermare, N. et al. Human thymus contains IFN---producing CD11c-, myeloid CD11c+, and mature interdigitating dendritic cells. J. Clin. Invest. 107, 835-844 (2001).
34. Pelayo, R. et al. Derivation of 2 categories of plasmacytoid dendritic cells in murine bone marrow. Blood 105, 4407-4415 (2005).
35. Schmid, M. A., Kingston, D., Boddupalli, S. & Manz, M. G. Instructive cytokine signals in dendritic cell lineage commitment. Immunol. Rev. 234, 32-44 (2010).
36. Waskow, C. et al. The receptor tyrosine kinase Flt3 is required for dendritic cell development in peripheral lymphoid tissues. Nat. Immunol. 9, 676-683 (2008).
37. Eidenschenk, C. et al. Flt3 permits survival during infection by rendering dendritic cells competent to activate NK cells. Proc. Natl Acad. Sci. USA 107, 9759-9764 (2010).
38. Laouar, Y., Welte, T., Fu, X. Y. & Flavell, R. A. STAT3 is required for Flt3L-dependent dendritic cell differentiation. Immunity 19, 903-912 (2003).
39. Sathaliyawala, T. et al. Mammalian target of rapamycin controls dendritic cell development downstream of Flt3 ligand signaling. Immunity 33, 597-606 (2010).
40. Scheffler, J. M. et al. LAMTOR2 regulates dendritic cell homeostasis through FLT3-dependent mTOR signalling. Nat. Commun. 5, 5138 (2014).
41. Chen, Y. L. et al. A type I IFN-Flt3 ligand axis augments plasmacytoid dendritic cell development from common lymphoid progenitors. J. Exp. Med. 210, 2515-2522 (2013).
42. Fancke, B., Suter, M., Hochrein, H. & O'Keeffe, M. M-CSF: a novel plasmacytoid and conventional dendritic cell poietin. Blood 111, 150-159 (2008).
43. MacDonald, K. P. et al. The colony-stimulating factor 1 receptor is expressed on dendritic cells during differentiation and regulates their expansion. J. Immunol. 175, 1399-1405 (2005).
44. Gilliet, M. et al. The development of murine plasmacytoid dendritic cell precursors is differentially regulated by FLT3-ligand and granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 195, 953-958 (2002).
45. Esashi, E. et al. The signal transducer STAT5 inhibits plasmacytoid dendritic cell development by suppressing transcription factor IRF8. Immunity 28, 509-520 (2008).
46. Nagasawa, M., Schmidlin, H., Hazekamp, M. G., Schotte, R. & Blom, B. Development of human plasmacytoid dendritic cells depends on the combined action of the basic helix-loop-helix factor E2-2 and the Ets factor Spi-B. Eur. J. Immunol. 38, 2389-2400 (2008).
47. Kee, B. L. E and ID proteins branch out. Nat. Rev. Immunol. 9, 175-184 (2009).
48. Ghosh, H. S., Cisse, B., Bunin, A., Lewis, K. L. & Reizis, B. Continuous expression of the transcription factor e2-2 maintains the cell fate of mature plasmacytoid dendritic cells. Immunity 33, 905-916 (2010).
49. Bar-On, L. et al. CX3CR1+ CD8-+ dendritic cells are a steady-state population related to plasmacytoid dendritic cells. Proc. Natl Acad. Sci. USA 107, 14745-14750 (2010).
50. Hacker, C. et al. Transcriptional profiling identifies Id2 function in dendritic cell development. Nat. Immunol. 4, 380-386 (2003).
51. Spits, H., Couwenberg, F., Bakker, A. Q., Weijer, K. & Uittenbogaart, C. H. Id2 and Id3 inhibit development of CD34+ stem cells into predendritic cell (pre-DC)2 but not into pre-DC1. Evidence for a lymphoid origin of pre-DC2. J. Exp. Med. 192, 1775-1784 (2000).
52. Li, H. S. et al. The signal transducers STAT5 and STAT3 control expression of Id2 and E2-2 during dendritic cell development. Blood 120, 4363-4373 (2012).
53. Ghosh, H. S. et al. ETO family protein Mtg16 regulates the balance of dendritic cell subsets by repressing Id2. J. Exp. Med. 211, 1623-1635 (2014).
54. Robbins, S. H. et al. Novel insights into the relationships between dendritic cell subsets in human and mouse revealed by genome-wide expression profiling. Genome Biol. 9, R17 (2008).
55. Rissoan, M. C. et al. Subtractive hybridization reveals the expression of immunoglobulin-like transcript 7, Eph-B1, granzyme B, and 3 novel transcripts in human plasmacytoid dendritic cells. Blood 100, 3295-3303 (2002).
56. Montes-Moreno, S. et al. SPIB, a novel immunohistochemical marker for human blastic plasmacytoid dendritic cell neoplasms: characterization of its expression in major hematolymphoid neoplasms. Blood 121, 643-647 (2013).
57. Schotte, R., Nagasawa, M., Weijer, K., Spits, H. & Blom, B. The ETS transcription factor Spi-B is required for human plasmacytoid dendritic cell development. J. Exp. Med. 200, 1503-1509 (2004).
58. Karrich, J. J. et al. The transcription factor Spi-B regulates human plasmacytoid dendritic cell survival through direct induction of the antiapoptotic gene BCL2-A1. Blood 119, 5191-5200 (2012).
59. Sasaki, I. et al. Spi-B is critical for plasmacytoid dendritic cell function and development. Blood 120, 4733-4743 (2012).
60. Wu, X. et al. Bcl11a controls Flt3 expression in early hematopoietic progenitors and is required for pDC development in vivo. PLoS ONE 8, e64800 (2013).
61. Ippolito, G. C. et al. Dendritic cell fate is determined by BCL11A. Proc. Natl Acad. Sci. USA 111, E998-E1006 (2014).
62. Schiavoni, G. et al. ICSBP is essential for the development of mouse type I interferon-producing cells and for the generation and activation of CD8-+ dendritic cells. J. Exp. Med. 196, 1415-1425 (2002).
63. Becker, A. M. et al. IRF-8 extinguishes neutrophil production and promotes dendritic cell lineage commitment in both myeloid and lymphoid mouse progenitors. Blood 119, 2003-2012 (2012).
64. Hambleton, S. et al. IRF8 mutations and human dendritic-cell immunodeficiency. N. Engl. J. Med. 365, 127-138 (2011).
65. Sawai, C. M. et al. Transcription factor Runx2 controls the development and migration of plasmacytoid dendritic cells. J. Exp. Med. 210, 2151-2159 (2013).
66. Miller, J. C. et al. Deciphering the transcriptional network of the dendritic cell lineage. Nat. Immunol. 13, 888-899 (2012).
67. Penna, G., Sozzani, S. & Adorini, L. Cutting edge: selective usage of chemokine receptors by plasmacytoid dendritic cells. J. Immunol. 167, 1862-1866 (2001).
68. Sozzani, S., Vermi, W., Del Prete, A. & Facchetti, F. Trafficking properties of plasmacytoid dendritic cells in health and disease. Trends Immunol. 31, 270-277 (2010).
69. Seth, S. et al. CCR7 essentially contributes to the homing of plasmacytoid dendritic cells to lymph nodes under steady-state as well as inflammatory conditions. J. Immunol. 186, 3364-3372 (2011).
70. Kohara, H. et al. Development of plasmacytoid dendritic cells in bone marrow stromal cell niches requires CXCL12-CXCR4 chemokine signaling. Blood 110, 4153-4160 (2007).
71. Umemoto, E. et al. Constitutive plasmacytoid dendritic cell migration to the splenic white pulp is cooperatively regulated by CCR7-and CXCR4-mediated signaling. J. Immunol. 189, 191-199 (2012).
72. Zou, W. et al. Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells. Nat. Med. 7, 1339-1346 (2001).
73. Krug, A. et al. IFN-producing cells respond to CXCR3 ligands in the presence of CXCL12 and secrete inflammatory chemokines upon activation. J. Immunol. 169, 6079-6083 (2002).
74. Diacovo, T. G., Blasius, A. L., Mak, T. W., Cella, M. & Colonna, M. Adhesive mechanisms governing interferon-producing cell recruitment into lymph nodes. J. Exp. Med. 202, 687-696 (2005).
75. Drobits, B. et al. Imiquimod clears tumors in mice independent of adaptive immunity by converting pDCs into tumor-killing effector cells. J. Clin. Invest. 122, 575-585 (2012).
76. Sisirak, V. et al. CCR6/CCR10-mediated plasmacytoid dendritic cell recruitment to inflamed epithelia after instruction in lymphoid tissues. Blood 118, 5130-5140 (2011).
77. Hadeiba, H. et al. Plasmacytoid dendritic cells transport peripheral antigens to the thymus to promote central tolerance. Immunity 36, 438-450 (2012).
78. Wendland, M. et al. CCR9 is a homing receptor for plasmacytoid dendritic cells to the small intestine. Proc. Natl Acad. Sci. USA 104, 6347-6352 (2007).
79. Wurbel, M. A., McIntire, M. G., Dwyer, P. & Fiebiger, E. CCL25/CCR9 interactions regulate large intestinal inflammation in a murine model of acute colitis. PLoS ONE 6, e16442 (2011).
80. Clahsen, T., Pabst, O., Tenbrock, K., Schippers, A. & Wagner, N. Localisation of dendritic cells in the gut epithelium requires MAdCAM-1. Clin. Immunol. 156, 74-84 (2014).
81. Marafioti, T. et al. Novel markers of normal and neoplastic human plasmacytoid dendritic cells. Blood 111, 3778-3792 (2008).
82. Srivatsan, S., Swiecki, M., Otero, K., Cella, M. & Shaw, A. S. CD2-associated protein regulates plasmacytoid dendritic cell migration, but is dispensable for their development and cytokine production. J. Immunol. 191, 5933-5940 (2013).
83. Gotoh, K. et al. Differential requirement for DOCK2 in migration of plasmacytoid dendritic cells versus myeloid dendritic cells. Blood 111, 2973-2976 (2008).
84. Kim, S. et al. Self-priming determines high type I IFN production by plasmacytoid dendritic cells. Eur. J. Immunol. 44, 807-818 (2014).
85. Kumagai, Y. et al. Cutting edge: TLR-dependent viral recognition along with type I IFN positive feedback signaling masks the requirement of viral replication for IFN-- production in plasmacytoid dendritic cells. J. Immunol. 182, 3960-3964 (2009).
86. Feng, Z. et al. Human pDCs preferentially sense enveloped hepatitis A virions. J. Clin. Invest. 125, 169-176 (2014).
87. Dreux, M. et al. Short-range exosomal transfer of viral RNA from infected cells to plasmacytoid dendritic cells triggers innate immunity. Cell Host Microbe 12, 558-570 (2012).
88. Frenz, T. et al. Independent of plasmacytoid dendritic cell (pDC) infection, pDC triggered by virus-infected cells mount enhanced type I IFN responses of different composition as opposed to pDC stimulated with free virus. J. Immunol. 193, 2496-2503 (2014).
89. Flores, M. et al. Fc-RIIB prevents inflammatory type I IFN production from plasmacytoid dendritic cells during a viral memory response. J. Immunol. 194, 4240-4250 (2015).
90. Bave, U. et al. Fc-RIIa is expressed on natural IFN---producing cells (plasmacytoid dendritic cells) and is required for the IFN-- production induced by apoptotic cells combined with lupus IgG. J. Immunol. 171, 3296-3302 (2003).
91. Barrat, F. J. et al. Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus. J. Exp. Med. 202, 1131-1139 (2005).
92. Means, T. K. et al. Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9. J. Clin. Invest. 115, 407-417 (2005).
93. Honda, K. et al. Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction. Nature 434, 1035-1040 (2005).
94. Guiducci, C. et al. Properties regulating the nature of the plasmacytoid dendritic cell response to Toll-like receptor 9 activation. J. Exp. Med. 203, 1999-2008 (2006).
95. Hoshino, K. et al. I-B kinase-- is critical for interferon-- production induced by Toll-like receptors 7 and 9. Nature 440, 949-953 (2006).
96. Shinohara, M. L. et al. Osteopontin expression is essential for interferon-- production by plasmacytoid dendritic cells. Nat. Immunol. 7, 498-506 (2006).
97. Cao, W. et al. Toll-like receptor-mediated induction of type I interferon in plasmacytoid dendritic cells requires the rapamycin-sensitive PI(3)K-mTOR-p70S6K pathway. Nat. Immunol. 9, 1157-1164 (2008).
98. Takaoka, A. et al. Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors. Nature 434, 243-249 (2005).
99. Purtha, W. E., Swiecki, M., Colonna, M., Diamond, M. S. & Bhattacharya, D. Spontaneous mutation of the Dock2 gene in Irf5-/-mice complicates interpretation of type I interferon production and antibody responses. Proc. Natl Acad. Sci. USA 109, E898-E904 (2012).
100. Sasai, M., Linehan, M. M. & Iwasaki, A. Bifurcation of Toll-like receptor 9 signaling by adaptor protein 3. Science 329, 1530-1534 (2010).
101. Blasius, A. L. et al. Slc15a4, AP-3, and Hermansky-Pudlak syndrome proteins are required for Toll-like receptor signaling in plasmacytoid dendritic cells. Proc. Natl Acad. Sci. USA 107, 19973-19978 (2010).
102. Henault, J. et al. Noncanonical autophagy is required for type I interferon secretion in response to DNA-immune complexes. Immunity 37, 986-997 (2012).
103. Lee, H. K., Lund, J. M., Ramanathan, B., Mizushima, N. & Iwasaki, A. Autophagy-dependent viral recognition by plasmacytoid dendritic cells. Science 315, 1398-1401 (2007).
104. Guo, H. et al. SCARB2/LIMP-2 Regulates IFN production of plasmacytoid dendritic cells by mediating endosomal translocation of TLR9 and nuclear translocation of IFN regulatory factor 7. J. Immunol. 194, 4737-4749 (2015).
105. Talukder, A. H. et al. Phospholipid scramblase 1 regulates Toll-like receptor 9-mediated type I interferon production in plasmacytoid dendritic cells. Cell Res. 22, 1129-1139 (2012).
106. Esashi, E., Bao, M., Wang, Y. H., Cao, W. & Liu, Y. J. PACSIN1 regulates the TLR7/9-mediated type I interferon response in plasmacytoid dendritic cells. Eur. J. Immunol. 42, 573-579 (2012).
107. Saitoh, T. et al. Antiviral protein Viperin promotes Toll-like receptor 7-and Toll-like receptor 9-mediated type I interferon production in plasmacytoid dendritic cells. Immunity 34, 352-363 (2011).
108. Gotoh, K. et al. Selective control of type I IFN induction by the Rac activator DOCK2 during TLR-mediated plasmacytoid dendritic cell activation. J. Exp. Med. 207, 721-730 (2010).
109. Wang, J., Lau, K. Y., Jung, J., Ravindran, P. & Barrat, F. J. Bruton's tyrosine kinase regulates TLR9 but not TLR7 signaling in human plasmacytoid dendritic cells. Eur. J. Immunol. 44, 1130-1136 (2014).
110. Koblansky, A. A. et al. Recognition of profilin by Toll-like receptor 12 is critical for host resistance to Toxoplasma gondii. Immunity 38, 119-130 (2013).
111. Dasgupta, S., Erturk-Hasdemir, D., Ochoa-Reparaz, J., Reinecker, H. C. & Kasper, D. L. Plasmacytoid dendritic cells mediate anti-inflammatory responses to a gut commensal molecule via both innate and adaptive mechanisms. Cell Host Microbe 15, 413-423 (2014).
112. Mazmanian, S. K., Liu, C. H., Tzianabos, A. O. & Kasper, D. L. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 122, 107-118 (2005).
113. Kim, T. et al. Aspartate-glutamate-alanine-histidine box motif (DEAH)/RNA helicase A helicases sense microbial DNA in human plasmacytoid dendritic cells. Proc. Natl Acad. Sci. USA 107, 15181-15186 (2010).
114. Cai, X., Chiu, Y. H. & Chen, Z. J. The cGAS-cGAMP-STING pathway of cytosolic DNA sensing and signaling. Mol. Cell 54, 289-296 (2014).
115. Bao, M. & Liu, Y. J. Regulation of TLR7/9 signaling in plasmacytoid dendritic cells. Protein Cell 4, 40-52 (2013).
116. Dzionek, A. et al. BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon -/- induction. J. Exp. Med. 194, 1823-1834 (2001).
117. Cao, W. et al. Plasmacytoid dendritic cell-specific receptor ILT7-Fc-RI- inhibits Toll-like receptor-induced interferon production. J. Exp. Med. 203, 1399-1405 (2006).
118. Fuchs, A., Cella, M., Kondo, T. & Colonna, M. Paradoxic inhibition of human natural interferon-producing cells by the activating receptor NKp44. Blood 106, 2076-2082 (2005).
119. Ju, X., Zenke, M., Hart, D. N. & Clark, G. J. CD300a/c regulate type I interferon and TNF-- secretion by human plasmacytoid dendritic cells stimulated with TLR7 and TLR9 ligands. Blood 112, 1184-1194 (2008).
120. Meyer-Wentrup, F. et al. Targeting DCIR on human plasmacytoid dendritic cells results in antigen presentation and inhibits IFN-- production. Blood 111, 4245-4253 (2008).
121. Cao, W. et al. Regulation of TLR7/9 responses in plasmacytoid dendritic cells by BST2 and ILT7 receptor interaction. J. Exp. Med. 206, 1603-1614 (2009).
122. Bonaccorsi, I. et al. The immune inhibitory receptor LAIR-1 is highly expressed by plasmacytoid dendritic cells and acts complementary with NKp44 to control IFN- production. PLoS ONE 5, e15080 (2010).
123. Bao, M. et al. CD2AP/SHIP1 complex positively regulates plasmacytoid dendritic cell receptor signaling by inhibiting the E3 ubiquitin ligase Cbl. J. Immunol. 189, 786-792 (2012).
124. Watarai, H. et al. PDC-TREM, a plasmacytoid dendritic cell-specific receptor, is responsible for augmented production of type I interferon. Proc. Natl Acad. Sci. USA 105, 2993-2998 (2008).
125. Tai, L. H. et al. Positive regulation of plasmacytoid dendritic cell function via Ly49Q recognition of class I MHC. J. Exp. Med. 205, 3187-3199 (2008).
126. Mitsuhashi, Y. et al. Regulation of plasmacytoid dendritic cell responses by PIR-B. Blood 120, 3256-3259 (2012).
127. Chiang, E. Y., Johnston, R. J. & Grogan, J. L. EBI2 is a negative regulator of type I interferons in plasmacytoid and myeloid dendritic cells. PLoS ONE 8, e83457 (2013).
128. Karrich, J. J. et al. MicroRNA-146a regulates survival and maturation of human plasmacytoid dendritic cells. Blood 122, 3001-3009 (2013).
129. Zhou, H. et al. miR-155 and its star-form partner miR-155 cooperatively regulate type I interferon production by human plasmacytoid dendritic cells. Blood 116, 5885-5894 (2010).
130. Agudo, J. et al. The miR-126-VEGFR2 axis controls the innate response to pathogen-associated nucleic acids. Nat. Immunol. 15, 54-62 (2014).
131. Seillet, C. et al. The TLR-mediated response of plasmacytoid dendritic cells is positively regulated by estradiol in vivo through cell-intrinsic estrogen receptor - signaling. Blood 119, 454-464 (2012).
132. Meier, A. et al. Sex differences in the Toll-like receptor-mediated response of plasmacytoid dendritic cells to HIV-1. Nat. Med. 15, 955-959 (2009).
133. Villadangos, J. A. & Young, L. Antigen-presentation properties of plasmacytoid dendritic cells. Immunity 29, 352-361 (2008).
134. Reizis, B., Bunin, A., Ghosh, H. S., Lewis, K. L. & Sisirak, V. Plasmacytoid dendritic cells: recent progress and open questions. Annu. Rev. Immunol. 29, 163-183 (2011).
135. Pallotta, M. T. et al. Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells. Nat. Immunol. 12, 870-878 (2011).
136. Fallarino, F. et al. Murine plasmacytoid dendritic cells initiate the immunosuppressive pathway of tryptophan catabolism in response to CD200 receptor engagement. J. Immunol. 173, 3748-3754 (2004).
137. Munn, D. H. et al. Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes. J. Clin. Invest. 114, 280-290 (2004).
138. Boasso, A. et al. HIV inhibits CD4+ T-cell proliferation by inducing indoleamine 2,3-dioxygenase in plasmacytoid dendritic cells. Blood 109, 3351-3359 (2007).
139. Ito, T. et al. Plasmacytoid dendritic cells prime IL-10- producing T regulatory cells by inducible costimulator ligand. J. Exp. Med. 204, 105-115 (2007).
140. Diana, J. et al. NKT cell-plasmacytoid dendritic cell cooperation via OX40 controls viral infection in a tissue-specific manner. Immunity 30, 289-299 (2009).
141. Diana, J. et al. Viral infection prevents diabetes by inducing regulatory T cells through NKT cell-plasmacytoid dendritic cell interplay. J. Exp. Med. 208, 729-745 (2011).
142. Jahrsdorfer, B. et al. Granzyme B produced by human plasmacytoid dendritic cells suppresses T-cell expansion. Blood 115, 1156-1165 (2010).
143. Hadeiba, H. et al. CCR9 expression defines tolerogenic plasmacytoid dendritic cells able to suppress acute graft-versus-host disease. Nat. Immunol. 9, 1253-1260 (2008).
144. Segura, E., Wong, J. & Villadangos, J. A. Cutting edge: B220+CCR9-dendritic cells are not plasmacytoid dendritic cells but are precursors of conventional dendritic cells. J. Immunol. 183, 1514-1517 (2009).
145. Lombardi, V., Speak, A. O., Kerzerho, J., Szely, N. & Akbari, O. CD8-+--and CD8-+-+ plasmacytoid dendritic cells induce Foxp3+ regulatory T cells and prevent the induction of airway hyper-reactivity. Mucosal Immunol. 5, 432-443 (2012).
146. Brown, A. S., Bourges, D., Ang, D. K., Hartland, E. L. & van Driel, I. R. CD8 subunit expression by plasmacytoid dendritic cells is variable, and does not define stable subsets. Mucosal Immunol. 7, 200-201 (2014).
147. Dalod, M. et al. Interferon -/- and interleukin 12 responses to viral infections: pathways regulating dendritic cell cytokine expression in vivo. J. Exp. Med. 195, 517-528 (2002).
148. Chappell, C. P. et al. Targeting antigens through blood dendritic cell antigen 2 on plasmacytoid dendritic cells promotes immunologic tolerance. J. Immunol. 192, 5789-5801 (2014).
149. Loschko, J. et al. Antigen targeting to plasmacytoid dendritic cells via Siglec-H inhibits Th cell-dependent autoimmunity. J. Immunol. 187, 6346-6356 (2011).
150. Loschko, J. et al. Antigen delivery to plasmacytoid dendritic cells via BST2 induces protective T cell-mediated immunity. J. Immunol. 186, 6718-6725 (2011).
151. Hoeffel, G. et al. Antigen crosspresentation by human plasmacytoid dendritic cells. Immunity 27, 481-492 (2007).
152. Mouries, J. et al. Plasmacytoid dendritic cells efficiently cross-prime naive T cells in vivo after TLR activation. Blood 112, 3713-3722 (2008).
153. Di Pucchio, T. et al. Direct proteasome-independent cross-presentation of viral antigen by plasmacytoid dendritic cells on major histocompatibility complex class I. Nat. Immunol. 9, 551-557 (2008).
154. Wang, Y., Swiecki, M., McCartney, S. A. & Colonna, M. dsRNA sensors and plasmacytoid dendritic cells in host defense and autoimmunity. Immunol. Rev. 243, 74-90 (2011).
155. Kumagai, Y. et al. Alveolar macrophages are the primary interferon-- producer in pulmonary infection with RNA viruses. Immunity 27, 240-252 (2007).
156. Cervantes-Barragan, L. et al. Control of coronavirus infection through plasmacytoid dendritic-cell-derived type I interferon. Blood 109, 1131-1137 (2007).
157. Cervantes-Barragan, L. et al. Plasmacytoid dendritic cells control T-cell response to chronic viral infection. Proc. Natl Acad. Sci. USA 109, 3012-3017 (2012).
158. Swiecki, M., Wang, Y., Gilfillan, S. & Colonna, M. Plasmacytoid dendritic cells contribute to systemic but not local antiviral responses to HSV infections. PLoS Pathog. 9, e1003728 (2013).
159. Ciancanelli, M. J. et al. Infectious disease. Life-threatening influenza and impaired interferon amplification in human IRF7 deficiency. Science 348, 448-453 (2015).
160. Davidson, S., Crotta, S., McCabe, T. M. & Wack, A. Pathogenic potential of interferon in acute influenza infection. Nat. Commun. 5, 3864 (2014).
161. Manches, O., Frleta, D. & Bhardwaj, N. Dendritic cells in progression and pathology of HIV infection. Trends Immunol. 35, 114-122 (2014).
162. Reeves, R. K. et al. SIV infection induces accumulation of plasmacytoid dendritic cells in the gut mucosa. J. Infect. Dis. 206, 1462-1468 (2012).
163. Lehmann, C. et al. Longitudinal analysis of distribution and function of plasmacytoid dendritic cells in peripheral blood and gut mucosa of HIV infected patients. J. Infect. Dis. 209, 940-949 (2014).
164. Li, H., Goepfert, P. & Reeves, R. K. Short communication: plasmacytoid dendritic cells from HIV-1 elite controllers maintain a gut-homing phenotype associated with immune activation. AIDS Res. Hum. Retroviruses 30, 1213-1215 (2014).
165. O'Brien, M., Manches, O. & Bhardwaj, N. Plasmacytoid dendritic cells in HIV infection. Adv. Exp. Med. Biol. 762, 71-107 (2013).
166. O'Brien, M. et al. Spatiotemporal trafficking of HIV in human plasmacytoid dendritic cells defines a persistently IFN---producing and partially matured phenotype. J. Clin. Invest. 121, 1088-1101 (2011).
167. Manches, O., Fernandez, M. V., Plumas, J., Chaperot, L. & Bhardwaj, N. Activation of the noncanonical NFB pathway by HIV controls a dendritic cell immunoregulatory phenotype. Proc. Natl Acad. Sci. USA 109, 14122-14127 (2012).
168. Volpi, C. et al. High doses of CpG oligodeoxynucleotides stimulate a tolerogenic TLR9-TRIF pathway. Nat. Commun. 4, 1852 (2013).
169. Li, G. et al. Plasmacytoid dendritic cells suppress HIV-1 replication but contribute to HIV-1 induced immunopathogenesis in humanized mice. PLoS Pathog. 10, e1004291 (2014).
170. Kader, M. et al. Blocking TLR7-and TLR9-mediated IFN-- production by plasmacytoid dendritic cells does not diminish immune activation in early SIV infection. PLoS Pathog. 9, e1003530 (2013).
171. Sandler, N. G. et al. Type I interferon responses in rhesus macaques prevent SIV infection and slow disease progression. Nature 511, 601-605 (2014).
172. Blasius, A. L., Krebs, P., Sullivan, B. M., Oldstone, M. B. & Popkin, D. L. Slc15a4, a gene required for pDC sensing of TLR ligands, is required to control persistent viral infection. PLoS Pathog. 8, e1002915 (2012).
173. Wang, Y. et al. Timing and magnitude of type I interferon responses by distinct sensors impact CD8 T cell exhaustion and chronic viral infection. Cell Host Microbe 11, 631-642 (2012).
174. Wilson, E. B. et al. Blockade of chronic type I interferon signaling to control persistent LCMV infection. Science 340, 202-207 (2013).
175. Teijaro, J. R. et al. Persistent LCMV infection is controlled by blockade of type I interferon signaling. Science 340, 207-211 (2013).
176. Ganguly, D., Haak, S., Sisirak, V. & Reizis, B. The role of dendritic cells in autoimmunity. Nat. Rev. Immunol. 13, 566-577 (2013).
177. Tian, J. et al. Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat. Immunol. 8, 487-496 (2007).
178. Garcia-Romo, G. S. et al. Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus. Sci. Transl Med. 3, 73ra20 (2011).
179. Lande, R. et al. Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in systemic lupus erythematosus. Sci. Transl Med. 3, 73ra19 (2011).
180. Campbell, A. M., Kashgarian, M. & Shlomchik, M. J. NADPH oxidase inhibits the pathogenesis of systemic lupus erythematosus. Sci. Transl Med. 4, 157ra141 (2012).
181. Morshed, M. et al. NADPH oxidase-independent formation of extracellular DNA traps by basophils. J. Immunol. 192, 5314-5323 (2014).
182. Guiducci, C. et al. TLR recognition of self nucleic acids hampers glucocorticoid activity in lupus. Nature 465, 937-941 (2010).
183. Lepelletier, Y. et al. Toll-like receptor control of glucocorticoid-induced apoptosis in human plasmacytoid predendritic cells (pDCs). Blood 116, 3389-3397 (2010).
184. Hong, Y. et al. miR-29b and miR-29c are involved in Toll-like receptor control of glucocorticoid-induced apoptosis in human plasmacytoid dendritic cells. PLoS ONE 8, e69926 (2013).
185. Soulier, A. et al. Cell-intrinsic regulation of murine dendritic cell function and survival by prereceptor amplification of glucocorticoid. Blood 122, 3288-3297 (2013).
186. Baccala, R. et al. Anti-IFN--/- receptor antibody treatment ameliorates disease in lupus-predisposed mice. J. Immunol. 189, 5976-5984 (2012).
187. Guiducci, C. et al. Autoimmune skin inflammation is dependent on plasmacytoid dendritic cell activation by nucleic acids via TLR7 and TLR9. J. Exp. Med. 207, 2931-2942 (2010).
188. Baccala, R. et al. Essential requirement for IRF8 and SLC15A4 implicates plasmacytoid dendritic cells in the pathogenesis of lupus. Proc. Natl Acad. Sci. USA 110, 2940-2945 (2013).
189. Kobayashi, T. et al. The histidine transporter SLC15A4 coordinates mTOR-dependent inflammatory responses and pathogenic antibody production. Immunity 41, 375-388 (2014).
190. Teichmann, L. L., Schenten, D., Medzhitov, R., Kashgarian, M. & Shlomchik, M. J. Signals via the adaptor MyD88 in B cells and DCs make distinct and synergistic contributions to immune activation and tissue damage in lupus. Immunity 38, 528-540 (2013).
191. Sisirak, V. et al. Genetic evidence for the role of plasmacytoid dendritic cells in systemic lupus erythematosus. J. Exp. Med. 211, 1969-1976 (2014).
192. Rowland, S. L. et al. Early, transient depletion of plasmacytoid dendritic cells ameliorates autoimmunity in a lupus model. J. Exp. Med. 211, 1977-1991 (2014).
193. Lande, R. et al. Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature 449, 564-569 (2007).
194. Ganguly, D. et al. Self-RNA-antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8. J. Exp. Med. 206, 1983-1994 (2009).
195. Lande, R. et al. Cationic antimicrobial peptides in psoriatic skin cooperate to break innate tolerance to self-DNA. Eur. J. Immunol. 45, 203-213 (2014).
196. Karthaus, N. et al. Vitamin D controls murine and human plasmacytoid dendritic cell function. J. Invest. Dermatol. 134, 1255-1264 (2014).
197. Diana, J. et al. Crosstalk between neutrophils, B-1a cells and plasmacytoid dendritic cells initiates autoimmune diabetes. Nat. Med. 19, 65-73 (2013).
198. Nestle, F. O. et al. Plasmacytoid predendritic cells initiate psoriasis through interferon-- production. J. Exp. Med. 202, 135-143 (2005).
199. Li, Q. et al. Interferon-- initiates type 1 diabetes in nonobese diabetic mice. Proc. Natl Acad. Sci. USA 105, 12439-12444 (2008).
200. Goubier, A. et al. Plasmacytoid dendritic cells mediate oral tolerance. Immunity 29, 464-475 (2008).
201. Contractor, N., Louten, J., Kim, L., Biron, C. A. & Kelsall, B. L. Cutting edge: Peyer's patch plasmacytoid dendritic cells (pDCs) produce low levels of type I interferons: possible role for IL-10, TGF-, and prostaglandin E2 in conditioning a unique mucosal pDC phenotype. J. Immunol. 179, 2690-2694 (2007).
202. Li, H. S. et al. Cell-intrinsic role for IFN-STAT1 signals in regulating murine Peyer patch plasmacytoid dendritic cells and conditioning an inflammatory response. Blood 118, 3879-3889 (2011).
203. Bonnefoy, F. et al. TGF---exposed plasmacytoid dendritic cells participate in Th17 commitment. J. Immunol. 186, 6157-6164 (2011).
204. Michea, P. et al. Epithelial control of the human pDC response to extracellular bacteria. Eur. J. Immunol. 43, 1264-1273 (2013).
205. Tezuka, H. et al. Prominent role for plasmacytoid dendritic cells in mucosal T cell-independent IgA induction. Immunity 34, 247-257 (2011).
206. Deal, E. M., Lahl, K., Narvaez, C. F., Butcher, E. C. & Greenberg, H. B. Plasmacytoid dendritic cells promote rotavirus-induced human and murine B cell responses. J. Clin. Invest. 123, 2464-2474 (2013).
207. Fujiwara, D. et al. Systemic control of plasmacytoid dendritic cells by CD8+ T cells and commensal microbiota. J. Immunol. 180, 5843-5852 (2008).
208. Berry, M. P. et al. An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 466, 973-977 (2010).
209. Facchetti, F. et al. Plasmacytoid monocytes (so-called plasmacytoid T cells) in granulomatous lymphadenitis. Hum. Pathol. 20, 588-593 (1989).
210. Saulep-Easton, D. et al. Cytokine-driven loss of plasmacytoid dendritic cell function in chronic lymphocytic leukemia. Leukemia 28, 2005-2015 (2014).
211. Wang, Y. et al. PTPN22 variant R620W associates with reduced TLR7-induced type 1 Interferon in SLE. Arthritis Rheum. (in the press) (2015).
212. van Bon, L. et al. Proteome-wide analysis and CXCL4 as a biomarker in systemic sclerosis. N. Engl. J. Med. 370, 433-443 (2014).
213. Ronnblom, L. & Eloranta, M. L. The interferon signature in autoimmune diseases. Curr. Opin. Rheumatol 25, 248-253 (2013).
214. Prete, F. et al. Wiskott-Aldrich syndrome protein-mediated actin dynamics control type-I interferon production in plasmacytoid dendritic cells. J. Exp. Med. 210, 355-374 (2013).
215. Sage, A. P. et al. MHC Class II-restricted antigen presentation by plasmacytoid dendritic cells drives proatherogenic T cell immunity. Circulation 130, 1363-1373 (2014).
216. Swiecki, M., Gilfillan, S., Vermi, W., Wang, Y. & Colonna, M. Plasmacytoid dendritic cell ablation impacts early interferon responses and antiviral NK and CD8+ T cell accrual. Immunity 33, 955-966 (2010).
217. Niederquell, M. et al. Sca-1 expression defines developmental stages of mouse pDCs that show functional heterogeneity in the endosomal but not lysosomal TLR9 response. Eur. J. Immunol. 43, 2993-3005 (2013).
218. Kamogawa-Schifter, Y. et al. Ly49Q defines 2 pDC subsets in mice. Blood 105, 2787-2792 (2005).
219. Bjorck, P., Leong, H. X. & Engleman, E. G. Plasmacytoid dendritic cell dichotomy: identification of IFN-- producing cells as a phenotypically and functionally distinct subset. J. Immunol. 186, 1477-1485 (2011).
220. O'Keeffe, M. et al. Nonplasmacytoid, high IFN---producing, bone marrow dendritic cells. J. Immunol. 188, 3774-3783 (2012).
221. Zucchini, N. et al. Individual plasmacytoid dendritic cells are major contributors to the production of multiple innate cytokines in an organ-specific manner during viral infection. Int. Immunol. 20, 45-56 (2008).
222. Allman, D. et al. Ikaros is required for plasmacytoid dendritic cell differentiation. Blood 108, 4025-4034 (2006).
223. Carotta, S. et al. The transcription factor PU.1 controls dendritic cell development and Flt3 cytokine receptor expression in a dose-dependent manner. Immunity 32, 628-641 (2010).
224. Janssens, S., Pulendran, B. & Lambrecht, B. N. Emerging functions of the unfolded protein response in immunity. Nat. Immunol. 15, 910-919 (2014).
225. Iwakoshi, N. N., Pypaert, M. & Glimcher, L. H. The transcription factor XBP-1 is essential for the development and survival of dendritic cells. J. Exp. Med. 204, 2267-2275 (2007).
226. Hirai, M. et al. Bortezomib suppresses function and survival of plasmacytoid dendritic cells by targeting intracellular trafficking of Toll-like receptors and endoplasmic reticulum homeostasis. Blood 117, 500-509 (2011).
227. Weigert, A. et al. HIF-1- is a negative regulator of plasmacytoid DC development in vitro and in vivo. Blood 120, 3001-3006 (2012).
228. Rathinam, C. et al. The transcriptional repressor Gfi1 controls STAT3-dependent dendritic cell development and function. Immunity 22, 717-728 (2005).
229. Chow, K. T., Schulz, D., McWhirter, S. M. & Schlissel, M. S. Gfi1 and gfi1b repress rag transcription in plasmacytoid dendritic cells in vitro. PLoS ONE 8, e75891 (2013).
230. Balzarolo, M. et al. The transcriptional regulator NAB2 reveals a two-step induction of TRAIL in activated plasmacytoid DCs. Eur. J. Immunol. 42, 3019-3027 (2012).
231. Tel, J. et al. Tumoricidal activity of human dendritic cells. Trends Immunol. 35, 38-46 (2014).
232. Hardy, A. W., Graham, D. R., Shearer, G. M. & Herbeuval, J. P. HIV turns plasmacytoid dendritic cells (pDC) into TRAIL-expressing killer pDC and down-regulates HIV coreceptors by Toll-like receptor 7-induced IFN--. Proc. Natl Acad. Sci. USA 104, 17453-17458 (2007).
233. Stary, G. et al. Plasmacytoid dendritic cells express TRAIL and induce CD4+ T-cell apoptosis in HIV-1 viremic patients. Blood 114, 3854-3863 (2009).
234. Colisson, R. et al. Free HTLV-1 induces TLR7-dependent innate immune response and TRAIL relocalization in killer plasmacytoid dendritic cells. Blood 115, 2177-2185 (2010).
235. Li, H. S., Greeley, N., Sugimoto, N., Liu, Y. J. & Watowich, S. S. miR-22 controls Irf8 mRNA abundance and murine dendritic cell development. PLoS ONE 7, e52341 (2012).
236. Chauvistre, H. et al. Dendritic cell development requires histone deacetylase activity. Eur. J. Immunol. 44, 2478-2488 (2014).
237. Treilleux, I. et al. Dendritic cell infiltration and prognosis of early stage breast cancer. Clin. Cancer Res. 10, 7466-7474 (2004).
238. Sisirak, V. et al. Impaired IFN-- production by plasmacytoid dendritic cells favors regulatory T-cell expansion that may contribute to breast cancer progression. Cancer Res. 72, 5188-5197 (2012).
239. Sisirak, V. et al. Breast cancer-derived transforming growth factor-- and tumor necrosis factor-- compromise interferon-- production by tumor-associated plasmacytoid dendritic cells. Int. J. Cancer 133, 771-778 (2013).
240. Palucka, A. K., Blanck, J. P., Bennett, L., Pascual, V. & Banchereau, J. Cross-regulation of TNF and IFN-- in autoimmune diseases. Proc. Natl Acad. Sci. USA 102, 3372-3377 (2005).
241. Faget, J. et al. ICOS is associated with poor prognosis in breast cancer as it promotes the amplification of immunosuppressive CD4 T cells by plasmacytoid dendritic cells. Oncoimmunology 2, e23185 (2013).
242. Labidi-Galy, S. I. et al. Plasmacytoid dendritic cells infiltrating ovarian cancer are associated with poor prognosis. Oncoimmunology 1, 380-382 (2012).
243. Labidi-Galy, S. I. et al. Quantitative and functional alterations of plasmacytoid dendritic cells contribute to immune tolerance in ovarian cancer. Cancer Res. 71, 5423-5434 (2011).
244. Tel, J. et al. Natural human plasmacytoid dendritic cells induce antigen-specific T-cell responses in melanoma patients. Cancer Res. 73, 1063-1075 (2013).
245. Le Mercier, I. et al. Tumor promotion by intratumoral plasmacytoid dendritic cells is reversed by TLR7 ligand treatment. Cancer Res. 73, 4629-4640 (2013).
246. Liu, C. et al. Plasmacytoid dendritic cells induce NK cell-dependent, tumor antigen-specific T cell cross-priming and tumor regression in mice. J. Clin. Invest. 118, 1165-1175 (2008).
247. Tel, J. et al. Human plasmacytoid dendritic cells are equipped with antigen-presenting and tumoricidal capacities. Blood 120, 3936-3944 (2012).
248. Petrella, T. et al. 'Agranular CD4+ CD56+ hematodermic neoplasm' (blastic NK-cell lymphoma) originates from a population of CD56+ precursor cells related to plasmacytoid monocytes. Am. J. Surg. Pathol. 26, 852-862 (2002).
249. Tabeta, K. et al. The Unc93b1 mutation 3d disrupts exogenous antigen presentation and signaling via Toll-like receptors 3, 7 and 9. Nat. Immunol. 7, 156-164 (2006).
250. Kim, Y. M., Brinkmann, M. M., Paquet, M. E. & Ploegh, H. L. UNC93B1 delivers nucleotide-sensing toll-like receptors to endolysosomes. Nature 452, 234-238 (2008).
251. Ewald, S. E. et al. The ectodomain of Toll-like receptor 9 is cleaved to generate a functional receptor. Nature 456, 658-662 (2008).
252. Park, B. et al. Proteolytic cleavage in an endolysosomal compartment is required for activation of Toll-like receptor 9. Nat. Immunol. 9, 1407-1414 (2008).